Tue, Oct 25, 2016
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index slips 0.29% in January; Healthcare & Biotechnology opens 2014 with 5.97% gain

Wednesday, February 19, 2014
Opalesque Industry Update - Hedge funds lost 0.29% in January, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index gained 11.11% in 2013.

“After a rousing end to 2013, January bore witness to a complete reversal of key trends as investor sentiment turned defensive,” says Sol Waksman, founder and president of BarclayHedge.

“Global equity markets sold off as emerging markets came under renewed pressure from slowing in China, political unrest in Thailand and Turkey, and currency devaluation in Argentina." Overall performance by hedge fund sector was mixed in January. Twelve of Barclay’s 18 hedge fund indices had gains, while six indices had losses.

The Barclay Healthcare & Biotechnology Index jumped 5.97% in January, its largest one-month return since posting a gain of 6.27% in May of 2009.

“The Healthcare sector was a beneficiary of the move by investors out of cyclical stocks and into defensive stocks,” says Waksman.

The Barclay Equity Short Bias was up 1.95% in January, Distressed Securities gained 1.55%, European Equities were up 1.20%, Convertible Arbitrage gained 1.10%, and Fixed Income Arbitrage rose 0.94%.

In contrast, the Emerging Markets Index lost 2.47%, Pacific Rim Equities were down 0.96%, Equity Long Bias gave up 0.86%, anf Global Macro lost 0.55%.

The Barclay Fund of Funds Index was down 0.36% in January.


Press Release


What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. M&A - U.S. hedge fund HarbourVest is shock winner in the £1.1bn SVG Capital takeover saga, Hedge fund Parvus shows hand, toppling William Hill merger deal[more]

    U.S. hedge fund HarbourVest is shock winner in the £1.1bn SVG Capital takeover saga From Thisismoney.co.uk: The fierce battle to buy Britain's biggest private equity group has come to an unexpected conclusion, with the original bidder walking away with the prize. SVG Capital has agreed

  2. Marc Lasry: Energy is still a phenomenal opportunity[more]

    From CNBC.com: Distressed debt specialist Marc Lasry said energy debt is still a "phenomenal opportunity" because investors can get "massively overpaid" for the risk they take on. There are "huge opportunities" in the energy sector especially in restructurings, the Avenue Capital Group CEO said Tues

  3. Opalesque Exclusive: Ex-SAC manager re-emerges with market neutral hedge fund[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: A manager re-emerged from the SAC battleground last year to launch his own hedge fund under the umbrella of New York-based investment firm Endicott Group.

  4. North America - Hedge-fund manager Kyle Bass says the U.S. is on track for stagflation, Billionaire hedge fund titans Dinan, Lasry on election, markets and best investment ideas[more]

    Hedge-fund manager Kyle Bass says the U.S. is on track for stagflation From Marketwatch.com: Kyle Bass, founder of Hayman Capital Management, on Wednesday warned that the U.S. is headed toward so-called stagflation. Stagflation is typically described as persistently high inflation and hi

  5. David Einhorn speaks on passive investing, Mylan, his cheapest stock, the Fed[more]

    From Forbes.com: Greenlight Capital hedge fund manager David Einhorn (Trades, Portfolio) joined nine other famed investors on Tuesday to talk about stocks at the annual Great Investors’ Best Ideas Investment Symposium in Dallas. Presenters at the annual conference typically pitch one or severa